https://www.avient.com/sites/default/files/2020-11/2020-advanced-composites-infographic.pdf
kui=vqJrAHhRKoTUzIO_kZai-w http://www.polyone.com
https://www.avient.com/sites/default/files/2022-08/IATF 16949 North Baltimore.doc.pdf
Facility: C & W Services 1404 Lowell Street Elyria, OH 44035 U.S.A.
https://www.avient.com/resources/safety-data-sheets?page=2753
CS WHITE W/ LM4 CS WHITE W/ LM3 CS WHITE W/ LM5
https://www.avient.com/sites/default/files/2023-01/AVNT Dec 2022 Earnings Presentation.pdf
Global Compact & fulfilled Communication of Progress (COP) requirements • New Sustainability Strategy overview page including our 2022 AIP ESG metrics • New ESG Performance page with ESG ratings, awards, and certifications • Increased disclosures on carbon emissions, including disclosure of Climate Change Scenario Analysis • Added new Product Stewardship and Chemical Management policies • Enhanced data reporting for Workforce Demographics • Improved social disclosures on human rights, dependent care and special leave and strategic training management 2021 SUSTAINABILITY REPORT Launching integrated sustainability website in parallel with report Aligned with leading reporting frameworks 6 Released July 2022 ESG RATINGS PERFORMANCE ESG AWARDS AND CERTIFICATIONS ESG PERFORMANCE & AWARDS 84th 3 1 2 7 T RAN S FO R MAT IO NAL OVE RV IE W Avient Protective Dyneema ® RECENT TRANSACTIONS Acquired Divested $1.45 B $0.95 B 9 Distribution UPDATED CAPITAL STRUCTURE & LIQUIDITY • Proceeds from completed sale of Distribution used to pay near-term maturing debt to strengthen balance sheet • Fixed/floating debt ratio of ~55/45 • Proven track record of deleveraging following major acquisitions through strong free cash flow generation • 2022 pro forma net debt/adjusted EBITDA expected to be 3.1x $725 $725 $575 $500 $600 $525 $650 $650 $600 Capital Structure Cas h $544 Undr awn Rev olve r $250 Liquidity $3.15B $2.40B 2030 Notes 2029 Term Loan 2026 Term Loan 2025 Notes 2023 Notes After Dyneema Acquisition After Distribution Divestiture $794M (1) $250M reflects estimated undrawn revolver following the divestiture of Distribution 10 PREVIOUS TRANSACTIONS Performance Solutions Products & $0.8 B COLOR $1.4 B Acquired (2020)Divested (2019) 11 • Acquisition of Clariant Color business significantly expanded presence in healthcare, packaging and consumer end markets • Strength of portfolio – double-digit annual EBITDA growth since acquisition • $75 million of realized synergies anticipated in 2022 • Acquisition completed on 2020年7月1日 for $1.45 billion. Purchase price multiple rapidly declining on strength of business and synergy capture 12 $133 $201 2019PF 2022E 12 Clariant Color EBITDA Growth Purchase Price Multiple 10.8x 7.0x 6.4x 2019PF 2021 2022E w/ Full Synergies 11.9% 16.3% 2019PF 2022E EBITDA Margins CLARIANT COLOR: TRANSFORMATIONAL ACQUISITION (1) Financial information is pro forma to include a full year of Clariant Color business SUNBELT PVC Resins DSS 20 Acquisitions $4.8B Investment $2.7B of Annual Revenue 5 Divestments $2.3B Proceeds TPE PP&S HISTORIC SPECIALIZATION THROUGH M&A 13 Distribution DSM Protective BOLT-ON ACQUISITION HISTORY 14 Commercial Resources Operating Income Operating Margins 259 363 $40 $139 Established Acquisitions (> 7 years) + 40% + 248% + 1300 bps I N V E S T T O G R O W SPECIALTY TRANSFORMATION T O D A Y 46% 67% 86% 0% 60% 80% 2005 2010 2019 2021 2022 PF % o f A d ju st ed E B IT D A • Commodity JVs • Distribution • Performance Products & Solutions • Specialty Businesses (1) Adjusted EBITDA is EBITDA excluding corporate costs and special items (2) Pro forma for the acquisition of Dyneema® and divestiture of Distribution (1 ) (2) 15 Building & 43% 14% Telecom. 2% 2006 2022 Pro Forma 21% Building & Telecom.
https://www.avient.com/sites/default/files/2025-01/AVNT Dec 2022 Earnings Presentation Updated.pdf
Global Compact & fulfilled Communication of Progress (COP) requirements • New Sustainability Strategy overview page including our 2022 AIP ESG metrics • New ESG Performance page with ESG ratings, awards, and certifications • Increased disclosures on carbon emissions, including disclosure of Climate Change Scenario Analysis • Added new Product Stewardship and Chemical Management policies • Enhanced data reporting for Workforce Demographics • Improved social disclosures on human rights, dependent care and special leave and strategic training management 2021 SUSTAINABILITY REPORT Launching integrated sustainability website in parallel with report Aligned with leading reporting frameworks 6 Released July 2022 ESG RATINGS PERFORMANCE ESG AWARDS AND CERTIFICATIONS ESG PERFORMANCE & AWARDS 84th 3 1 2 7 T RAN S FO R MAT IO NAL OVE RV IE W Avient Protective Dyneema ® RECENT TRANSACTIONS Acquired Divested $1.45 B $0.95 B 9 Distribution UPDATED CAPITAL STRUCTURE & LIQUIDITY • Proceeds from completed sale of Distribution used to pay near-term maturing debt to strengthen balance sheet • Fixed/floating debt ratio of ~55/45 • Proven track record of deleveraging following major acquisitions through strong free cash flow generation • 2022 pro forma net debt/adjusted EBITDA expected to be 3.1x $725 $725 $575 $500 $600 $525 $650 $650 $600 Capital Structure Cash $544 Undrawn Revolver $250 Liquidity $3.15B $2.40B 2030 Notes 2029 Term Loan 2026 Term Loan 2025 Notes 2023 Notes After Dyneema Acquisition After Distribution Divestiture $794M (1) $250M reflects estimated undrawn revolver following the divestiture of Distribution 10 PREVIOUS TRANSACTIONS Performance Solutions Products & $0.8 B COLOR $1.4 B Acquired (2020)Divested (2019) 11 • Acquisition of Clariant Color business significantly expanded presence in healthcare, packaging and consumer end markets • Strength of portfolio – double-digit annual EBITDA growth since acquisition • $75 million of realized synergies anticipated in 2022 • Acquisition completed on 2020年7月1日 for $1.45 billion. Purchase price multiple rapidly declining on strength of business and synergy capture 12 $133 $201 2019PF 2022E 12 Clariant Color EBITDA Growth Purchase Price Multiple 10.8x 7.0x 6.4x 2019PF 2021 2022E w/ Full Synergies 11.9% 16.3% 2019PF 2022E EBITDA Margins CLARIANT COLOR: TRANSFORMATIONAL ACQUISITION (1) Financial information is pro forma to include a full year of Clariant Color business SUNBELT PVC Resins DSS 20 Acquisitions $4.8B Investment $2.7B of Annual Revenue 5 Divestments $2.3B Proceeds TPE PP&S HISTORIC SPECIALIZATION THROUGH M&A 13 Distribution DSM Protective BOLT-ON ACQUISITION HISTORY 14 Commercial Resources Operating Income Operating Margins 259 363 $40 $139 Established Acquisitions (> 7 years) + 40% + 248% + 1300 bps I N V E S T T O G R O W SPECIALTY TRANSFORMATION T O D A Y 46% 67% 86% 0% 60% 80% 2005 2010 2019 2021 2022 PF % o f A d ju st ed E B IT D A • Commodity JVs • Distribution • Performance Products & Solutions • Specialty Businesses (1) Adjusted EBITDA is EBITDA excluding corporate costs and special items (2) Pro forma for the acquisition of Dyneema® and divestiture of Distribution (1 ) (2) 15 Building & 43% 14% Telecom. 2% 2006 2022 Pro Forma 21% Building & Telecom.
https://www.avient.com/resources/safety-data-sheets?page=6083
UV GRAY ABS 800043 GLOBAL WHITE UV 682 ABS GRAY 104622
https://www.avient.com/resources/safety-data-sheets?page=4164
GRAY 106752 GRAY 106304 GRAY 104615
https://www.avient.com/sites/default/files/2022-07/MEVOPUR Chemical Foaming Agents Application Bulletin_CN.pdf
主要特性 根据ISO 13485规定的程序生产 变更控制记录的级别高于CAS编号级别,降低 变更风险 可用于常规注塑机和挤出设备—由技术支持团 队提供设置支持 可用于聚烯烃、苯乙烯和共聚物 可与着色剂联用 注册药品管理档案(III类)和/或医疗器械主 文件 食品接触声明符合美国FDA和EU规范 法规支持 原材料根据以下法规测试:- ISO 10993-1 - USP第、章(包含VI级) - 欧洲药典,各论3.1.3/3.1.5章节(聚烯烃包 装材料) - 美国药典(聚乙烯) - 杂质元素符合ICH Q3D要求 轻量化 1.844.4AVIENT www.avient.com 版权所有© 2022埃万特公司。
https://www.avient.com/sites/default/files/2021-09/mevopur-colors-for-needle-hubs-bulletin-cn.pdf
主要特性 在三个通过ISO 13485认证的医疗生产线生 产全球统一的配方,提供全球一致性和供应 链保障 变更控制记录不限于CAS编号级别,降低变 更风险 不含动物源性物质和邻苯二甲酸盐 可将颜色与添加剂相结合,以增强产品性能 和防护性能 法规支持 经过预测试的原材料:- 美国药典(USP)23,第87和88章(VI类) 萃取和生物学评价 - ISO 10993,第4、5、10、11和18部分, 萃取和生物学评价 - 美国药典和欧洲药典中针对USP 、 ICH Q3D可萃取金属和EP3.1聚烯烃的测试的 其他监管支持信息 FDA器械主文件 食品接触符合FDA/EU*要求 针头的标称外径 (mm) 颜色说明 RAL 潘通色号 透明产品代码 不透明产品代码 0.4 中灰色 7035 423 C PP7M665125 PP7M665127 0.45 褐色 8017 7588 C PP8M665294 PP8M665296 0.5 橘黄色 2003 173 C PP2M665298 PP2M665300 0.55 中紫色 4005 7676 C PP4M665290 PP4M665292 0.6 深蓝色 5010 288 C PP5M665894 PP5M665896 0.7 黑色 9005 黑色 C PP9M664950 PP9M664952 0.8 深绿色 6001 7483 C PP6M665687 PP6M665689 0.9 黄色 1021 115 C PP1M665211 PP1M665213 1.1 乳白色 1015 7401 C PP0M665290 PP0M665292 1.2 粉色 3015 502 C PE3M665725 PP3M665727 适用医疗保健使用限制—见下文。
https://www.avient.com/sites/default/files/2022-05/MEVOPUR LQ for Silicone Elastomers_CN.pdf
可根据要求提供多种定制化 颜色解决方案 根据ISO 13485/GMP质量体系生产,并拥有变 更控制管理 原材料红外光谱分析和常规批次检测 根据ISO 10993第18部分对正己烷、异丙醇及 水中的可萃取性进行评估 法规支持 原材料根据ISO 10993-1和USP第、 章(VI类)对原材料进行生物评估的预测试 向FDA提交所有标准颜色的DMF/MAF文件 应用 医疗器械,如导管和连接器、注射器针头及无 针连接器 与皮肤接触设备,如可穿戴设备或医疗器械的 柔软触感表面 MEVOPUR LQ 配方可用于要求严苛的应用,包 括:MEVOPUR™-LQ 不透明红(PMS198C) 产品编号:FZ3M415008 MEVOPUR™-LQ 透明红 产品编号:FZ3M415009 MEVOPUR™-LQ 不透明蓝(PMS292C) 产品编号:FZ5M415008 MEVOPUR™-LQ 透明蓝 产品编号:FZ5M415009 MEVOPUR™-LQ 不透明黄(PMS1205C) 产品编号:FZ1M415005 MEVOPUR™-LQ 透明黄 产品编号:FZ1M415006 MEVOPUR™-LQ 不透明绿(PMS346C) 产品编号:FZ6M415008 MEVOPUR™-LQ 透明绿 产品编号:FZ6M415009 MEVOPUR™-LQ 不透明紫(PMS2655C) 产品编号:FZ4M415003 MEVOPUR™-LQ 透明紫 产品编号:FZ4M415004 定制化选择 也可以根据您的需求 定制颜色, 请联系我们。